209 related articles for article (PubMed ID: 23688495)
1. Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter?
Fleming ML; Chandwani H; Barner JC; Weber SN; Okoro TT
J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):136-42. PubMed ID: 23688495
[TBL] [Abstract][Full Text] [Related]
2. How does use of a prescription monitoring program change pharmacy practice?
Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
J Am Pharm Assoc (2003); 2013; 53(3):273-81. PubMed ID: 23699676
[TBL] [Abstract][Full Text] [Related]
3. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
[TBL] [Abstract][Full Text] [Related]
4. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.
Thomas CP; Kim M; Nikitin RV; Kreiner P; Clark TW; Carrow GM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):950-7. PubMed ID: 24920376
[TBL] [Abstract][Full Text] [Related]
5. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators.
Katz N; Houle B; Fernandez KC; Kreiner P; Thomas CP; Kim M; Carrow GM; Audet A; Brushwood D
Pain Med; 2008; 9(5):587-94. PubMed ID: 18565002
[TBL] [Abstract][Full Text] [Related]
6. How does use of a prescription monitoring program change medical practice?
Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
Pain Med; 2012 Oct; 13(10):1314-23. PubMed ID: 22845339
[TBL] [Abstract][Full Text] [Related]
7. Exploratory study of emergency physicians' use of a prescription monitoring program using a framework of technology acceptance.
Fleming ML; Hatfield MD; Wattana MK; Todd KH
J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):19-27. PubMed ID: 24520884
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
9. The influence of prescription monitoring programs on chronic pain management.
Wang J; Christo PJ
Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
[TBL] [Abstract][Full Text] [Related]
10. Factors Influencing Judgments to Consult Prescription Monitoring Programs: A Factorial Survey Experiment.
Witry MJ; St Marie BJ; Viyyuri BR; Windschitl PD
Pain Manag Nurs; 2020 Feb; 21(1):48-56. PubMed ID: 31133408
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing community pharmacists' enrollment in a state prescription monitoring program.
Ulbrich TR; Dula CA; Green CG; Porter K; Bennett MS
J Am Pharm Assoc (2003); 2010; 50(5):588-94. PubMed ID: 20833616
[TBL] [Abstract][Full Text] [Related]
12. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
Kuo GM; Touchette DR; Marinac JS
Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas.
Thornton JD; Varisco TJ; Downs CG
Pharmacoepidemiol Drug Saf; 2021 Apr; 30(4):492-503. PubMed ID: 33458926
[TBL] [Abstract][Full Text] [Related]
14. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels S; Novak S
Res Social Adm Pharm; 2014; 10(2):285-96. PubMed ID: 23816495
[TBL] [Abstract][Full Text] [Related]
15. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
[TBL] [Abstract][Full Text] [Related]
16. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
[TBL] [Abstract][Full Text] [Related]
17. Concern about the Expanding Prescription Drug Epidemic: A Survey of Licensed Prescribers and Dispensers.
Wright RE; Reed N; Carnes N; Kooreman HE
Pain Physician; 2016 Jan; 19(1):E197-208. PubMed ID: 26752487
[TBL] [Abstract][Full Text] [Related]
18. Impact of a drug utilization review program on high-risk use of prescription controlled substances.
Daubresse M; Gleason PP; Peng Y; Shah ND; Ritter ST; Alexander GC
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):419-27. PubMed ID: 23881609
[TBL] [Abstract][Full Text] [Related]
19. Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(3):509-14. PubMed ID: 26329535
[TBL] [Abstract][Full Text] [Related]
20. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo B
Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
